| 1 |
35345424 | Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study. | 2022 |
2 |
| 2 |
33261310 | Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism. | 2020 Dec |
2 |
| 3 |
25337775 | Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans. | 2015 Apr |
2 |
| 4 |
24405838 | Spironolactone, not furosemide, improved insulin resistance in patients with chronic heart failure. | 2014 Feb 15 |
4 |
| 5 |
23461841 | Serum free fatty acid levels in PCOS patients treated with glucophage, magnesium oxide and spironolactone. | 2013 May |
2 |
| 6 |
22733474 | Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients. | 2012 Aug |
2 |
| 7 |
21436212 | Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease. | 2011 Dec |
2 |
| 8 |
17885557 | A possible association between primary aldosteronism and a lower beta-cell function. | 2007 Oct |
1 |
| 9 |
18075971 | Effects of spironolactone on glucose transport and interleukin-6 secretion in adipose cells of women. | 2007 Dec |
1 |
| 10 |
15816371 | Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile. | 2005 Jan |
4 |
| 11 |
8845091 | Hypertension in patients with diabetes mellitus. | 1995 Dec |
1 |